Matt Lucas
Director
Microbiology
Biotech Umea
Sweden
Biography
Matt Lucas is currently Director of Chemistry at Yumanity therapeutics. A successful Leader and Manager with 14 years’ industrial experience in medicinal chemistry and drug discovery, Dr. Lucas has led multiple projects from discovery into clinical development, and has a deep knowledge of what is required to successfully optimize lead compounds and to select appropriate clinical candidates. Dr. Lucas has been exposed to diverse therapy areas including anti-infectives, pain, cardiovascular, immunology, and neuroscience that has given him a broad understanding of the various challenges in drug discovery. Prior to joining Yumanity, Dr. Lucas was Director of Medicinal Chemistry and member of the Discovery and Non-Clinical Development Research Leadership Team at Cubist Pharmaceuticals until it was acquired by Merck Research Laboratories. Before joining Cubist, Dr. Lucas worked at Roche Pharmaceuticals as sites in Palo Alto, Basel and Nutley.
Research Interest
microbiology
